» Articles » PMID: 31885899

The Effect of Hypertension Duration and the Age of Onset on CV Risk Factors Expression in Perimenopausal Women

Overview
Journal Int J Hypertens
Publisher Wiley
Date 2019 Dec 31
PMID 31885899
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of hypertension duration and the time of onset on the expression of metabolic syndrome (MS) and other CV risk factors, in perimenopausal women, have not been studied so far. Methods. A total of 202 women, old 47-59 years, and diagnosed with hypertension, were recruited from primary care practices in eastern Croatia. The categories of hypertension duration were defined as <5, 5-10, and >10 years. Data were analyzed by standard statistical procedures.

Results: The proportion of women with MS increases in parallel with hypertension duration ( = 0.025). Among the examined CV risk factors, significant increase in parallel with hypertension duration was found for body mass index ( = 0.007) and triglycerides ( = 0.07). The highest proportion of women with diabetes duration of less than 5 years, indicating recent diabetes onset, was found in the category of hypertension duration of less than 5 years, corresponding with the onset of hypertension in the time around menopause ( = 0.003). The strongest linear correlations with BMI and waist circumference were found for total serum cholesterol ( = 0.355 and 0.499, respectively).

Conclusion: Hypertension onset at the time around menopause appears together with abdominal obesity and may be a driving force for CV risk factor accumulation in postmenopausal women.

Citing Articles

The gender and age perspectives of allostatic load.

Volaric N, Sojat D, Volaric M, Vcev I, Keskic T, Majnaric L Front Med (Lausanne). 2025; 11:1502940.

PMID: 39741506 PMC: 11685202. DOI: 10.3389/fmed.2024.1502940.


Cross-Talk between the Cytokine IL-37 and Thyroid Hormones in Modulating Chronic Inflammation Associated with Target Organ Damage in Age-Related Metabolic and Vascular Conditions.

Majnaric L, Bosnic Z, Stefanic M, Wittlinger T Int J Mol Sci. 2022; 23(12).

PMID: 35742902 PMC: 9224418. DOI: 10.3390/ijms23126456.


Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity.

Bosnic Z, Yildirim P, Babic F, Sahinovic I, Wittlinger T, Martinovic I Healthcare (Basel). 2021; 9(12).

PMID: 34946413 PMC: 8700975. DOI: 10.3390/healthcare9121687.


Neutrophil-to-Lymphocyte Ratio as a Cardiovascular Risk Marker May Be Less Efficient in Women Than in Men.

Majnaric L, Guljas S, Bosnic Z, Seric V, Wittlinger T Biomolecules. 2021; 11(4).

PMID: 33918155 PMC: 8066649. DOI: 10.3390/biom11040528.

References
1.
Spoto B, Pisano A, Zoccali C . Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016; 311(6):F1087-F1108. DOI: 10.1152/ajprenal.00340.2016. View

2.
Chae C, Derby C . The menopausal transition and cardiovascular risk. Obstet Gynecol Clin North Am. 2011; 38(3):477-88. DOI: 10.1016/j.ogc.2011.05.005. View

3.
Inker L, Astor B, Fox C, Isakova T, Lash J, Peralta C . KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014; 63(5):713-35. DOI: 10.1053/j.ajkd.2014.01.416. View

4.
Landsberg L, Aronne L, Beilin L, Burke V, Igel L, Lloyd-Jones D . Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich). 2013; 15(1):14-33. PMC: 8108268. DOI: 10.1111/jch.12049. View

5.
Freeman E . Associations of depression with the transition to menopause. Menopause. 2010; 17(4):823-7. DOI: 10.1097/gme.0b013e3181db9f8b. View